Conquer Cancer, the ASCO Foundation shared a post on LinkedIn:
“What happens when we support oncology’s brightest minds early in their careers? We pave the way for historic discoveries.
At the recent ASCO Annual Meeting, past Conquer Cancer grant recipients Dr. Brian Wolpin and Dr. Mark Dickson presented practice-changing Phase 3 trial results—including a daily pill that doubles survival for patients with pancreatic cancer and a targeted therapy that dramatically slows tumor growth for rare sarcoma.
These milestones were over 15 years in the making. Progress begins when donor funds promote early career ideas. Discover how early investment leads to global breakthroughs.”
Read “36 Posts Not To Miss From 2026 ASCO Week” on OncoDaily.
